TiumBio Co Ltd
KOSDAQ:321550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TiumBio Co Ltd
KOSDAQ:321550
|
KR |
|
Delta Resources Ltd
XTSX:DLTA
|
CA |
|
Iress Ltd
F:BRF
|
AU |
|
Intesa Sanpaolo SpA
MIL:ISP
|
IT |
|
S
|
Sensirion Holding AG
SIX:SENS
|
CH |
|
S
|
Suncorp Group Ltd
F:SU4
|
AU |
|
L
|
London City Equities Ltd
ASX:LCE
|
AU |
|
V
|
Volatus Aerospace Inc
F:ABB
|
CA |
|
Boustead Singapore Ltd
SGX:F9D
|
SG |
|
I
|
Imperial Resources Inc
OTC:IPRC
|
US |
|
Greenbriar Sustainable Living Inc
XTSX:GRB
|
CA |
|
S
|
Sony Group Corp
SWB:SONA
|
JP |
Intrinsic Value
Is TiumBio Co Ltd undervalued or overvalued?
See the intrinsic value estimate for TiumBio Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
TiumBio Co Ltd looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with TiumBio Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What TiumBio Does
TiumBio is a South Korean biotech company that develops medicines for rare and hard-to-treat diseases, with a strong focus on blood disorders such as hemophilia. It does not run a broad consumer business; instead, it works in drug research, preclinical and clinical development, and the preparation of new treatments for later approval and sale.
- Headquarters
- Korea KR
- IPO date
- Nov 22, 2019
Earnings Waterfall
TiumBio Co Ltd
The intrinsic value for TiumBio Co Ltd (321550) under the Base Case is hidden KRW.
Compared with the current market price of 4 215 KRW, the stock appears hidden.